LAUSR

Abstract IA12: Developing combinatorial therapies for KRAS-driven cancers

Sign Up to like & get
recommendations!
2 Published in 2023 at "Molecular Cancer Research"

DOI: 10.1158/1557-3125.ras23-ia12

Abstract: The RAS pathway is one of the most commonly deregulated pathways in human cancer. Approximately 30% of all tumors harbor activating mutations in either KRAS, NRAS or HRAS, and even more possess alterations in other… read more here.

Keywords: abstract ia12; combinatorial therapies; driven cancers; developing combinatorial ... See more keywords